A preclinical evidence supports that EGCG from flavanols can significantly attenuate clinical symptoms (like pruritus) and pathologic features (like epidermal hyperplasia and dermal inflammatory cells infiltration) on imiquimod-induced psoriasis-like mice via restraining OS and inflammation-related pathways especially Akt signaling pathway [73]. Here, AKT1 is linked to psoriasis.